![](/img/cover-not-exists.png)
The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells
Greve, Gabriele, Schiffmann, Insa, Pfeifer, Dietmar, Pantic, Milena, Schüler, Julia, Lübbert, MichaelVolume:
15
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-015-1967-5
Date:
December, 2015
File:
PDF, 3.05 MB
english, 2015